|
PCGF6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.918400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.248200E-01 |
| Normal-vs-Stage2 |
8.313000E-01 |
| Normal-vs-Stage3 |
3.790200E-01 |
| Normal-vs-Stage4 |
2.196800E-01 |
| Stage1-vs-Stage2 |
5.744000E-01 |
| Stage1-vs-Stage3 |
2.331400E-01 |
| Stage1-vs-Stage4 |
2.296600E-01 |
| Stage2-vs-Stage3 |
4.965600E-01 |
| Stage2-vs-Stage4 |
4.126200E-01 |
| Stage3-vs-Stage4 |
9.555400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.676800E-01 |
| Normal-vs-AfricanAmerican |
3.499800E-01 |
| Normal-vs-Asian |
6.952800E-01 |
| Caucasian-vs-AfricanAmerican |
1.233630E-01 |
| Caucasian-vs-Asian |
4.125800E-01 |
| AfricanAmerican-vs-Asian |
9.461000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.393200E-01 |
| Normal-vs-Female |
6.163500E-02 |
| Male-vs-Female |
2.840900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.964200E-01 |
| Normal-vs-Extreme_Weight |
2.827600E-01 |
| Normal-vs-Obese |
5.867200E-01 |
| Normal-vs-Extreme_Obese |
1.503150E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.429600E-01 |
| Normal_Weight-vs-Obese |
3.613000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.344600E-01 |
| Extreme_Weight-vs-Obese |
1.132570E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.777600E-01 |
| Obese-vs-Extreme_Obese |
1.017420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.760500E-02 |
| Normal-vs-Age(41-60Yrs) |
4.587000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.934200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.789700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.394400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.047990E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.363100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.066300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.270500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.620600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.867800E-01 |
| Normal-VS-Type2 PRCC |
5.998300E-03 |
| Normal-VS-KIRP CIMP |
9.378100E-03 |
| Normal-VS-Unclassified PRCC |
5.518800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.035600E-04 |
| Type1 PRCC-VS-KIRP CIMP |
9.378400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.956200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.839000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.819300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.246450E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.290800E-01 |
| Normal-vs-N1 |
2.768000E-02 |
| Normal-vs-N2 |
6.165600E-01 |
| N0-vs-N1 |
2.578100E-03 |
| N0-vs-N2 |
9.265600E-01 |
| N1-vs-N2 |
2.370400E-01 |
|
|
